Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
Efficacy and dosage data were analyzed for patients who received methyldopa up to 4.5 years. A prompt initial response to methyldopa was observed, and the blood pressure reduction was maintained throughout the follow-up period. Mean dosage rose modestly during this time.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies
D004232:Diuretics; D008750:Methyldopa